1 min listen
Treating Cancer using Targeted Radiotherapeutics with Jack Hoppin and John Babich of Ratio Therapeutics
Treating Cancer using Targeted Radiotherapeutics with Jack Hoppin and John Babich of Ratio Therapeutics
ratings:
Length:
27 minutes
Released:
Jul 26, 2023
Format:
Podcast episode
Description
Today we have Dr. Jack Hoppin CEO of Ratio Therapeutics and Dr. John Babich Chief Science Officer of Ratio Therapeutics. The team at Ratio Therapeutics is developing a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers. They just recently opened a 19,000-square-foot headquarters and R&D facility in Boston to continue their exciting innovation. We’ll dive into how Ratio started, their growth, and what you can learn from their journey from Lab to Launch. Show notes:https://ratiotx.com/ Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez
Released:
Jul 26, 2023
Format:
Podcast episode
Titles in the series (97)
Trailer by From Lab to Launch by Qualio